Hypersensitivity reactions to oxaliplatin: cross-reactivity to carboplatin and the introduction of a desensitization schedule.
Meyer
Lars
L
Zuberbier
Torsten
T
Worm
Margitta
M
Oettle
Helmut
H
Riess
Hanno
H
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D007262:Infusions, Intravenous; D009944:Organoplatinum Compounds / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D000077150:Oxaliplatin; D012720:Severity of Illness Index; D012882:Skin Tests; D013997:Time Factors
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin